The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells

• Lotte M.E. Berghauser Pont,

  Affiliation Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Anne Kleijn,

  Affiliation Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Jenneke J. Kloezeman,

  Affiliation Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Wouter van den Bossche,

  Affiliation Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Johanna K. Kaufmann,

  Affiliation Department of Neurosurgery, Harvey Cushing Neuro-Oncology Laboratories, Brigham & Women’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jeroen de Vrij,

  Affiliation Department of Neurosurgery, Utrecht University Medical Center, Utrecht, The Netherlands

  ⨯
• Sieger Leenstra,

  Affiliations Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands, Department of Neurosurgery, Elisabeth Hospital, Tilburg, The Netherlands

  ⨯
• Clemens M.F. Dirven,

  Affiliation Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands

  ⨯
• Martine L.M. Lamfers

  * E-mail: m.lamfers@erasmusmc.nl

  Affiliation Department of Neurosurgery, Brain Tumor Center, Erasmus MC, Rotterdam, The Netherlands

  ⨯